Elsevier

Biochemical Pharmacology

Volume 43, Issue 3, 4 February 1992, Pages 539-543
Biochemical Pharmacology

Interaction of dolastatin 10 with bovine brain tubulin

https://doi.org/10.1016/0006-2952(92)90576-5Get rights and content

Abstract

Dolastatin 10 is an unusual peptide of marine origin which binds to tubulin in the vinblastine/ maytansine/phomopsin-binding region and potently inhibits mitosis. Using N, N′-ethylenebis(iodoacetamide) (EBI) and iodo[14C]acetamide as probes for the effects of ligands on the thiol groups of tubulin, we found that dolastatin 10 has effects on the sulfhydryls indistinguishable from those of phomopsin A but quite different from those of vinblastine and maytansine. Using the binding of bis-5,5'-[8-(N-phenyl) aminonaphthalene-1-sulfonic acid](BisANS) as a measure of tubulin decay, we found that dolastatin 10 resembled phomopsin A in that decay was not detectable by this assay in its presence. Interestingly, both otherwise very different peptides are among the most effective inhibitors of tubulin decay yet discovered.

References (30)

Cited by (51)

  • Marine resource: A promising future for anticancer drugs

    2013, Studies in Natural Products Chemistry
    Citation Excerpt :

    They can bind to CD2, CD3, and CD4 in T lymphocytes and enhance the proliferative response of T lymphocytes [215,216]. Compared with other sulfated polysaccharides, fucoidans have been increasingly investigated in recent years to develop as drug or functional food [217,218]. They represent one of the sulfated polysaccharides (sulfated l-fucose) derived from cell wall of brown algae [219,220].

  • Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds

    2010, Mitochondrion
    Citation Excerpt :

    As such, mitochondrial dysfunction and increased ROS generation in cancer cells may render them more sensitive to curcumin. Pancratistatin (PST) is a natural compound isolated from the spider lily Pancratium littorale (Pettit et al., 1984; Luduena et al., 1992). It seems to preferentially target mitochondria in cancer cells and induce apoptosis in multiple cancer cell lines while exhibiting little harmful effect to their non-cancerous counterparts (McLachlan et al., 2005; Pandey et al., 2005; Siedlakowski et al., 2008).

  • The cutting edge: Apoptosis and therapeutic opportunity

    2007, Artificial Cells, Cell Engineering and Therapy
View all citing articles on Scopus
View full text